Alcohol Linked with Lobular Breast Cancer (09-3-2010)

Although alcohol is a well-established risk factor for breast cancer, it may be more strongly linked with lobular breast cancer than with ductal breast cancer. These results were published in the Journal of the National Cancer Institute. Research suggests... Continue Reading

Rectal Cancer Increasing in People Under 40 (09-2-2010)

Although still relatively uncommon in young people, the incidence of rectal cancer appears to be increasing in this population. These results were published in the journal Cancer. Colorectal cancer is the second leading cause of cancer death in the United... Continue Reading

Early Palliative Care Linked with Longer Lung Cancer Survival (09-1-2010)

Palliative care is care that is focused on symptom management, psychosocial issues, decision-making, and quality of life. Among patients with newly diagnosed, metastatic, non-small cell lung cancer, the addition of early palliative care to standard cancer... Continue Reading

Istodax Active against Refractory Cutaneous T-cell Lymphoma (08-31-2010)

Final results from a Phase II clinical trial provide additional evidence that Istodax® (romidepsin) is active against refractory cutaneous T-cell lymphoma. These results were published in the Journal of Clinical Oncology. Cutaneous T-cell lymphoma (CTCL)... Continue Reading

Estrogen Alone Does Not Increase Lung Cancer Incidence or Mortality in Postmenopausal Women (08-30-2010)

Among postmenopausal women, hormone therapy with estrogen alone does not appear to increase the risk of getting or dying from lung cancer. These results were published in the Journal of the National Cancer Institute. As women reach menopause and beyond,... Continue Reading

Reduced-intensity Treatment May be Effective for Early Hodgkin’s Lymphoma (08-27-2010)

Among patients with early-stage Hodgkin’s lymphoma and a favorable prognosis, it may be possible to reduce the number of chemotherapy cycles and the dose of radiation therapy without adversely affecting outcome. The results of this study were published... Continue Reading

Death from Other Causes Among Men with Early-stage Prostate Cancer (08-26-2010)

Among men with early-stage prostate cancer, assessment of other health problems may help guide prostate cancer treatment decisions; men who are likely to die of causes other than prostate cancer may not benefit from aggressive prostate cancer treatment.... Continue Reading

Vectibix Does Not Improve Head and Neck Cancer Survival (08-26-2010)

Among patients with recurrent and/or metastatic, squamous cell head and neck cancer, the addition of the targeted therapy Vectibix® (panitumumab) to chemotherapy does not result in significantly better survival than chemotherapy alone. The results of... Continue Reading

Pathological Complete Response Predicts Better Outcomes in Locally Advanced Rectal Cancer Patients (08-25-2010)

Among patients with locally advanced rectal cancer, a complete disappearance of detectable cancer (pathological complete response) after preoperative chemoradiation therapy is linked with better long-term outcomes. These findings were recently published... Continue Reading

Additional Research on Menopausal Hormone Therapy and Breast Cancer (08-24-2010)

A recent study of menopausal hormone therapy and risk of breast cancer reported that risk may vary by body weight and the type of hormone therapy. These results were published in Cancer Epidemiology, Biomarkers, & Prevention. As women reach menopause... Continue Reading

Reassuring Findings Regarding Oral Bisphosphonates and Esophageal Cancer (08-23-2010)

Oral bisphosphonates—drugs commonly used to prevent or treat osteoporosis—do not appear to increase the risk of esophageal cancer. These results were published in the Journal of the American Medical Association. Osteoporosis—a condition characterized... Continue Reading

Randomized Study Does Not Support Use of Methylphenidate for Cancer-related Fatigue (08-20-2010)

The results of a Phase III study indicate that overall, long-acting methylphenidate is ineffective in the management of cancer-related fatigue. Methylphenidate may provide some benefit, however, to certain subgroups of patients, such as those with advanced... Continue Reading